By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc. (AVAH)

NASDAQ Currency in USD
$368.00
+$3.08
+0.84%
Last Update: 18 Jul 2026, 11:31
$74.90bn
Market Cap
303.31
P/E Ratio (TTM)
Forward Dividend Yield
$240.68-$464.90
52 Week Range

AVAH Stock Price Chart

Explore Aveanna Healthcare Holdings Inc. interactive price chart. Choose custom timeframes to analyze AVAH price movements and trends.

AVAH Company Profile

Discover essential business fundamentals and corporate details for Aveanna Healthcare Holdings Inc. (AVAH) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Care Facilities

IPO Date

28 Apr 2021

Employees

33.50k

CEO

Jeffrey S. Shaner

Description

Aveanna Healthcare Holdings Inc. operates as a diverse platform for home-based care services throughout the United States. The company delivers a range of critical offerings, including private duty nursing (PDN), adult home health and hospice care, in-home pediatric therapy, and enteral nutrition services. Its patient-centered approach allows individuals to receive essential medical care within their own homes, effectively reducing the need for costly institutional settings such as hospitals. The company's operations are structured into three key segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment provides specialized private duty nursing, which includes skilled nursing care for medically fragile children at home, nursing support in school environments, and services at pediatric day healthcare centers. This segment also offers employer-of-record support, personal care services, and pediatric therapy (physical, occupational, and speech) provided both in clinics and patients' residences. The HHH segment focuses on home health services, encompassing in-home skilled nursing, physical, occupational, and speech therapy, as well as medical social work and aide assistance. Furthermore, it delivers hospice services, offering compassionate care to patients and their families when life-limiting illnesses no longer respond to curative treatments. The MS segment supplies enteral nutrition products and other vital medical supplies to adults and children, distributed on either a scheduled or as-needed basis. Founded in 2016, Aveanna Healthcare Holdings Inc. is headquartered in Atlanta, Georgia.

AVAH Financial Timeline

Browse a chronological timeline of Aveanna Healthcare Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 6 Aug 2026

EPS estimate is $0.17, while revenue estimate is $638.61m.

Earnings released on 14 May 2026

EPS came in at $0.18 surpassing the estimated $0.13 by +38.46%, while revenue for the quarter reached $647.92m , beating expectations by +5.66%.

Earnings released on 19 Mar 2026

EPS came in at $0.17 surpassing the estimated $0.15 by +10.53%, while revenue for the quarter reached $662.48m , beating expectations by +3.02%.

Earnings released on 6 Nov 2025

EPS came in at $0.15 surpassing the estimated $0.08 by +87.50%, while revenue for the quarter reached $621.94m , missing expectations by -4.24%.

Earnings released on 7 Aug 2025

EPS came in at $0.18 surpassing the estimated $0.04 by +350.00%, while revenue for the quarter reached $589.55m , beating expectations by +9.13%.

Earnings released on 8 May 2025

EPS came in at $0.10 surpassing the estimated $0.03 by +216.76%, while revenue for the quarter reached $559.22m , beating expectations by +6.06%.

Earnings released on 13 Mar 2025

EPS came in at $0.05 surpassing the estimated $0.00 by +1.18k%, while revenue for the quarter reached $519.87m , beating expectations by +0.72%.

Earnings released on 7 Nov 2024

EPS came in at $0.02 surpassing the estimated $0.01 by +253.98%, while revenue for the quarter reached $509.02m , beating expectations by +1.92%.

Earnings released on 8 Aug 2024

EPS came in at $0.01 surpassing the estimated $0.00 by +150.00%, while revenue for the quarter reached $504.96m , beating expectations by +2.35%.

Earnings released on 9 May 2024

EPS came in at -$0.03 surpassing the estimated -$0.05 by +40.00%, while revenue for the quarter reached $490.65m , beating expectations by +1.38%.

Earnings released on 14 Mar 2024

EPS came in at -$0.01 falling short of the estimated -$0.01 by -15.74%, while revenue for the quarter reached $478.84m , beating expectations by +2.45%.

Earnings released on 9 Nov 2023

EPS came in at -$0.03 falling short of the estimated -$0.03 by -12.49%, while revenue for the quarter reached $478.01m , beating expectations by +2.60%.

Earnings released on 10 Aug 2023

EPS came in at -$0.02 falling short of the estimated -$0.01 by -44.82%, while revenue for the quarter reached $471.95m , beating expectations by +3.14%.

Earnings released on 11 May 2023

EPS came in at -$0.05 surpassing the estimated -$0.06 by +16.67%, while revenue for the quarter reached $466.41m , beating expectations by +3.18%.

Earnings released on 16 Mar 2023

EPS came in at -$0.03 falling short of the estimated -$0.02 by -81.05%, while revenue for the quarter reached $451.15m , beating expectations by +0.67%.

Earnings released on 9 Nov 2022

EPS came in at -$0.03 falling short of the estimated -$0.01 by -185.71%, while revenue for the quarter reached $443.01m , missing expectations by -0.84%.

Earnings released on 10 Aug 2022

EPS came in at $0.03 falling short of the estimated $0.06 by -50.00%, while revenue for the quarter reached $442.96m , missing expectations by -1.70%.

Earnings released on 11 May 2022

EPS came in at $0.04 falling short of the estimated $0.06 by -33.33%, while revenue for the quarter reached $450.53m , beating expectations by +3.73%.

Earnings released on 28 Mar 2022

EPS came in at $0.10 falling short of the estimated $0.11 by -9.09%, while revenue for the quarter reached $414.07m , missing expectations by -0.78%.

Earnings released on 15 Nov 2021

EPS came in at $0.11 falling short of the estimated $0.12 by -8.33%, while revenue for the quarter reached $411.28m , missing expectations by -2.49%.

Earnings released on 11 Aug 2021

EPS came in at $0.10 matching the estimated $0.10, while revenue for the quarter reached $436.11m , meeting expectations.

AVAH Stock Performance

Access detailed AVAH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run